FLAMMA

COMPANY PROFILE

Flamma Group is a family-owned, fully integrated small-molecule CDMO offering global cGMP API development and manufacturing services.

FLAMMA is a family owned & run, award winning, fully integrated CDMO with Headquarters located near Milan, Italy. FLAMMA specializes in the cGMP manufacturing of small molecule APIs, NCEs, RSMs & advanced intermediates. FLAMMA has significant expertise in high value chiral materials (specifically amino acid related materials used in peptide drugs). FLAMMA provides manufacturing options for the entire life cycle of a small molecule drug.

FLAMMA can provide assistance for early stage pre-clinical development (from g to kg using our facility located outside of Philadelphia in the USA) to large-scale commercial manufacturing (from 100’s of kg to MT) at one of our three facilities located in Italy. FLAMMA’s 100% owned and self-managed facility in Dalian, China allows one to leverage its offerings to provide a stable and secure supply chain. With over 850 employees and a total capacity of 1,100 m3 (900 m3 in Italy and 200 m3 in China), learn why FLAMMA is a preferred supplier to the pharmaceutical and biotech industry. Visit FlammaGroup.com for further information.

Type of Drugs Manufactured:

Small Molecule

CDMO Services offer:

Drug Substance Manufacturing (API)

No. of Manufacturing Facilities:

3-5

High Potent Products capabilities:

OEB 3;OEB 4-5

Facilities Locations:

Europe;North America;China

Current Capacity:

Capacity is very project specific. We encourage potential customers to contact us for a quick assessment of their project. With our highly technical BD team, we can quickly communicate the options whether it is Italy only, USA only, or some sort of combination approach by leveraging all our sites.

Certification

United States FDA, Europe EMA, GMP, Japan PMDA, China NMPA, Brazil ANVISA, Canada Health Canada, Italy AIFA